Overview
ZEISS provides comprehensive microscopy solutions for pharmaceutical R&D and biopharma, including light, confocal, electron, and X-ray microscopes with AI-powered image analysis software. Their offerings span high-resolution imaging, live-cell imaging, 3D volumetric analysis, and high-content screening, supported by both capital equipment sales and flexible Microscopy as a Service options. ZEISS integrates advanced automation, machine learning segmentation, and expert workflows to accelerate drug discovery, tissue analysis, and quality assurance. The company serves life sciences research, materials characterization, and clinical diagnostics with proven infrastructure and customizable solutions.
Frequently asked questions
- What microscopy modalities does ZEISS offer for pharmaceutical research?
- ZEISS offers light microscopes, confocal systems (LSM Airyscan), electron microscopes, and X-ray microscopes. Their platforms support high-resolution imaging, live-cell imaging, super-resolution imaging, 3D volumetric imaging, and high-plex fluorescence imaging with spectral unmixing capabilities for multiplexed marker detection.
- Does ZEISS provide service-based alternatives to capital equipment purchases?
- Yes. ZEISS Microscopy as a Service provides access to cutting-edge imaging technologies, proven workflows, and expert support without requiring capital equipment investment. Services include high-resolution imaging, 3D analysis, tissue multiplexing, high-content screening, and slide scanning tailored to life sciences and biopharma needs.
- What AI and automation capabilities does ZEISS integrate into their systems?
- ZEISS incorporates AI-powered image analysis through ZEN and arivis software, featuring automated segmentation, cell tracking, and quantitative measurements. Their ZEN Guided Acquisition Module integrates microscopy automation with AI-powered analysis, and their Xradia 3D X-ray platform uses deep learning-based reconstruction to accelerate data acquisition by over 10X while maintaining image quality.